VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Fernandez Discusses Immunotherapy Plus Radiation Therapy for Prostate Cancer

Eduardo Fernandez, MD, PhD, FACRO
Published: Monday, Oct 06, 2014

Eduardo Fernandez, MD, PhD, FACRO, Senior Vice President, Medical Affairs / Medical Director for Latin America, Radiation Oncologist, 21st Century Oncology, discusses the potential for immunotherapy and radiation therapy to be used together to treat prostate cancer.

Fernandez says the role that immunotherapy plays when combined with radiation therapy is finally starting to be understood. Researchers know now that radiation therapy triggers an immune response. By enhancing the immune response, radiation therapy can also be enhanced, Fernandez says.

Sipuleucel-T (Provenge) activates the immune system against the prostate cancer cells. While sipuleucel-T has demonstrated benefit, researchers are looking to further these benefits by combining it with radiation. ​
Eduardo Fernandez, MD, PhD, FACRO, Senior Vice President, Medical Affairs / Medical Director for Latin America, Radiation Oncologist, 21st Century Oncology, discusses the potential for immunotherapy and radiation therapy to be used together to treat prostate cancer.

Fernandez says the role that immunotherapy plays when combined with radiation therapy is finally starting to be understood. Researchers know now that radiation therapy triggers an immune response. By enhancing the immune response, radiation therapy can also be enhanced, Fernandez says.

Sipuleucel-T (Provenge) activates the immune system against the prostate cancer cells. While sipuleucel-T has demonstrated benefit, researchers are looking to further these benefits by combining it with radiation. ​



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x